Detalles de la búsqueda
1.
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study.
Clin Lymphoma Myeloma Leuk
; 24(4): 224-231.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212206
2.
Prostate cancer across four countries in the Middle East: a multi-centre, observational, retrospective and prognostic study.
Ecancermedicalscience
; 18: 1695, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774566
3.
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 41(2): 696-715, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110653
4.
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 41(4): 1576-1593, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402374
Resultados
1 -
4
de 4
1
Próxima >
>>